Newsroom
CONTACTS
Media: 212.994.8200
Investors: Shalini Sharp, 800.962.2436
Recent Press Releases
| DATE |
TITLE (click to view) |
| December 31, 2009 | Antigenics Receives NASDAQ Delisting Notification |
| November 20, 2009 | European CHMP Formally Adopts Negative Opinion on Oncophage® |
| November 4, 2009 | Antigenics Provides Details On GlaxoSmithKline’s Pivotal Malaria Vaccine Trial With QS-21 Adjuvant |
| October 29, 2009 | Antigenics Reports Third Quarter 2009 Financial Results |
| October 26, 2009 | Data Presented On Oncophage Cancer Vaccine In Recurrent Glioma At SNO 2009 |
| October 22, 2009 | Antigenics to Report Third Quarter 2009 Financial Results on October 29, 2009; Conference Call to Follow |
| October 21, 2009 | Antigenics Announces a Negative Vote From the CHMP on Oncophage® Marketing Application in Europe |
| September 21, 2009 | Antigenics Announces Expansion of its QS-21 License Agreement |
| August 12, 2009 | Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics’ Oncophage® Cancer Vaccine in Newly Diagnosed Glioma |
| August 4, 2009 | Antigenics to Raise $10 Million in Private Placement |
| |
More news releases » |
|
|
Click to download the essential documents about Antigenics.
(1 MB .zip) |
|
|
